NOI HT941026N0110 MAMC Yttrium 90 Micro Resin Spheres.pdf

Notice of Intent to Sole Source

HT941026N0110

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE PURCHASE ORDER

CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD- W), Echo Branch intends to negotiate and award a firm-fixed price five year Blanket Purchase Agreement (BPA) to supply Sirtex Medical, Inc.., for SIR-Spheres (Yttium-90 Micro Resin Spheres) and accessories for Madigan Army Medical Center, WA, in accordance with Federal Acquisition Regulation (FAR) 12.102(b), restricting competition, only one source being available to meet the Government’s needs to:

Sirtex Medical, Inc.

300 Unicorn Park DR FL 2, Woburn, Massachusetts, 01801-3363

UEI: CWH2GM13A2V6

CAGE: 45EE6

The North American Industry Classification System (NAICS) code for this requirement is 325412 - Pharmaceutical Preparation Manufacturing; the business size standard is 1,3000 (# of employees). The Product Service Code (PSC) is 3650, chemical and pharmaceutical products manufacturing machinery.

The objective of this procurement is to execute a sole-source, five-year Blanket Purchase Agreement (BPA) with Sirtex Medical, Inc. for SIR-Spheres (Yttrium-90 Micro Resin Spheres) to support the operational needs of the Department of Radiology at Madigan Army Medical Center (MAMC), Washington. This FDA-approved treatment is essential for several clinical applications at MAMC, primarily for patients whose primary colorectal (bowel) cancer has metastasized to the liver and cannot be surgically removed, as well as for primary, unresectable liver cancer to control solitary tumors. It is also utilized as a bridge to transplant or surgery by controlling or "downstaging" tumor growth, and is the current treatment used for patients at MAMC with this stage of liver cancer. During the procedure, microscopic resin beads containing radioactive Yttrium-90 (Y-90) are selectively delivered via a catheter into the hepatic artery, lodging in the tumor’s blood vessels to provide localized, high-dose radiation that spares surrounding healthy liver tissue. Market research, including a review of historical acquisition data and industry publications, confirmed that this must be a sole-source award because Sirtex Medical, Inc. is the sole manufacturer, distributor, and commercial license holder of SIR-Spheres Y-90 Resin Microspheres and does not utilize third-party vendors. An analysis using NAICS code 325412 (Pharmaceutical Preparation Manufacturing) confirmed that no small business distributors are capable of fulfilling this requirement due to the exclusive rights held by Sirtex Medical, Inc.

Delivery Period: 1 October 2026 to 30 September 2031

Delivery Location: Madigan Army Medical Center, Bldg. 9040A Jackson Ave., Joint Base Lewis McChord, WA 98431

Based on market research and previous acquisition history, it has been determined that Sirtex Medical, Inc., is the only source that can meet the Government’s specialized requirement.

This notice of intent is not a request for competitive proposals, and no formal solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement. Submissions must include management, technical, and cost data in sufficient detail accompanied by convincing evidence to clearly demonstrate the capability to provide the required equipment and preventive maintenance. Capability statements shall not exceed four (4) pages (8.5" x 11" format) using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. Requests for documentation, inquiries for additional information, or submissions consisting solely of questions will not be considered affirmative responses. A determination by the Government not to compete this requirement based on responses to this notice is solely within the discretion of the Government. Information received will be considered exclusively for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole-source purchase order.

Response Instructions:

If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to:

• Cha-on Gordon at cha-on.p.gordon2.civ@health.mil

• Mariangela Monsalve at mariangela.j.monsalve.civ@health.mil

The closing date for challenges is no later than 1000 Pacific Daylight Time, Tuesday, September 8, 2026.

NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

https://www.google.com/url?q=mailto%3Acha-on.p.gordon2.civ%40health.mil mailto:mariangela.j.monsalve.civ@mail.mil